pharma · Melanoma · HIV Infections
Bristol Myers Squibb
Bristol-Myers Squibb
Bristol Myers Squibb clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3401 Princeton Pike, Lawrence Township, NJ 08648, US
- Employees
- 38,146
- Programs
- 40
- Drugs
- 17
- Patents
- 25
Bristol Myers Squibb projects
7 ClinicalTrials.gov programs sponsored by Bristol Myers Squibb.
Bristol Myers Squibb has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
BMS-641988 (AR#2)
Bristol-Myers Squibb
Prostate Cancer
1 trial -
BMS-906024
Bristol-Myers Squibb
Cancer
1 trial -
BMS-986148
Bristol-Myers Squibb
Advanced Cancer
1 trial -
BMS-986202
Bristol-Myers Squibb
Psoriasis
1 trial -
BMS-986500
Bristol-Myers Squibb
Advanced Solid Tumor
1 trial -
CC-122
Bristol-Myers Squibb
Non-Hodgkin Lymphoma
1 trial -
Nivolumab
Bristol-Myers Squibb
Melanoma
1 trial
Frequently asked questions
How many clinical projects does Bristol Myers Squibb have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.